GlobalData on MSN12d
FDA authorises ImmunityBio’s BCG alternative to treat bladder cancer
ImmunityBio has gained US Food and Drug Administration (FDA) authorisation for an expanded access programme to supply an ...
Hosted on MSN4d
IAVI and Biofabri dose first adults and teens in TB vaccine trial
IAVI and Biofabri are collaborating on the trial, which will recruit around 4,300 patients with latent TB infections across ...
FiercePharma13d
Amid Merck supply squeeze, ImmunityBio and Serum Institute snag FDA blessing for BCG expanded access program
The FDA has authorized ImmunityBio’s expanded access program to bring alternative sources of the cancer-fighting bacteria BCG ...
Cancer Therapy Advisor11d
FDA Allows Use of Recombinant BCG Through Expanded Access Program
The FDA has authorized an expanded access program that will allow for the use of a recombinant bacillus Calmette-Guerin product.
The Financial Express9d
New mRNA vaccine against tuberculosis effectively boosts immunity, study reveals
Currently, the most widely used vaccine against TB is the Bacillus Calmette-Guérin (BCG). Developed in 1921, the vaccine ...
Malay Mail on MSN12d
Leprosy outbreak in Negeri Sembilan: Here’s everything you need to know about the disease
KUALA LUMPUR, Feb 20 — Negeri Sembilan is currently experiencing an outbreak of leprosy with nine reported cases so far and ...